TIDMAGI

RNS Number : 2579E

AGI Therapeutics plc

04 April 2011

AGI Therapeutics plc ('AGI')

Holding in Company

AGI was notified on 4 April 2011 that Irish Life Investment Managers had decreased its shareholding to 2,474,049 Ordinary Shares representing 3.67% of AGI's Issued Share Capital.

Contact Information

AGI Therapeutics

David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUSSORASASRAR

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos AGI.
AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos AGI.